Biodesix
BDSX
52 hedge funds and large institutions have $111M invested in Biodesix in 2024 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 14 increasing their positions, 6 reducing their positions, and 5 closing their positions.
140% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 5
133% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 6
36% more capital invested
Capital invested by funds: $82M → $111M (+$29.2M)
13% more funds holding
Funds holding: 46 → 52 (+6)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.19% less ownership
Funds ownership: 2.34% → 2.15% (-0.19%)
67% less call options, than puts
Call options by funds: $6K | Put options by funds: $18K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WSFS
Wilmington Savings Fund Society
Wilmington,
Delaware
|
+$10.5M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$4.74M |
| 3 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$3.01M |
| 4 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$533K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$466K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$3.57M |
| 2 |
LP
LMR Partners
London,
United Kingdom
|
-$2.45M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$353K |
| 4 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$172K |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$63K |
BDSX Hedge Fund Activity: Q3 2024 in Review
52 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Biodesix (BDSX) for Q3 2024, worth a combined $111M — up 36% from $82M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new BDSX positions and 5 closed out — a net gain of 7 holders — while 14 added to existing stakes and 6 trimmed.
The largest buyer was Wilmington Savings Fund Society, opening a new position worth an estimated $10.5M. The largest seller was Soleus Capital Management, cutting an estimated $3.57M.
- 52 institutional investors held Biodesix (BDSX) as of Q3 2024, up from 46 in Q2 2024.
- Funds reported $111M of Biodesix stock for Q3 2024, up 36% quarter-over-quarter.
- 12 funds opened new Biodesix positions in Q3 2024 and 5 closed out, a net change of +7 holders.
- The largest Biodesix buyer in Q3 2024 was Wilmington Savings Fund Society, an estimated $10.5M added.
- The largest Biodesix seller in Q3 2024 was Soleus Capital Management, an estimated $3.57M sold.
Based on aggregated 13F filings for Q3 2024.